Leading Clinical Trial Technology Company Noted for Impressive Growth and
NEW YORK, September 5 /CNW/ - Medidata Solutions today announced its
recent recognition in Inc. magazine's first-ever Inc. 5,000 list of the
fastest-growing private companies in the United States. A global provider of
electronic clinical data capture (EDC), management and reporting solutions,
Medidata Solutions placed 13th in the Inc. 5,000 New York, New Jersey and Long
Island region, 14th in the Inc. 5,000 software industry category and 173rd in
the overall Inc. 5,000 with a three-year growth rate of 1,193.4 percent.
Medidata's inclusion in the ranking has been highlighted in the September
issue of Inc. magazine, which attributes the company's expansion to the
growing adoption of the Medidata Rave(R) software solution within the
pharmaceutical industry. Medidata Rave enables life sciences companies to
electronically collect, manage and report on data from clinical studies of
drugs and medical devices to increase the efficiency and safety of bringing
life-enhancing treatments to market.
"Our consistent high growth for each of the past three years and key
placement in Inc.'s ranking is a result of our increased customer
relationships with life sciences companies of all sizes, successful
partnerships with leading technology and services providers and strength of
our management and professional teams," said Tarek Sherif, CEO of Medidata
Solutions. "We expect sustained momentum for the company as Medidata Rave
continues to be viewed as the gold standard of clinical trial technology for
biopharmaceutical and medical device companies around the world."
The 2007 Inc. 5,000 list measures revenue growth from 2003 through 2006
and reported median revenue of $9.4 million and median three-year growth of
140 percent. To qualify, companies had to be U.S.-based and privately held,
independent - not subsidiaries or divisions of other companies - as of
December 31, 2006, and had at least $200,000 in revenue in 2003 and two
million dollars in 2006. Complete information on this year's Inc. 5,000, can
be found at www.inc.com/inc5000.
The health industry reported the third-highest total revenue in 2006 with
$13.1 billion, following construction ($27.1 billion) and manufacturing ($18.6
billion) and leading computers and electronics ($12.7 billion) and financial
services ($11.8 billion).
"The Inc. 5,000 provides the most comprehensive look ever at the most
important part of the economy - the entrepreneurial part," said Inc. 5,000
Project Manager Jim Melloan. "The expansion of the list has allowed us to tell
the stories of larger companies, older companies and a wealth of companies in
industries like manufacturing and construction that are underreported in the
Inc.com, the Daily Resource for Entrepreneurs, delivers advice, tools,
breaking news, and rich multi-media to help business owners and CEOs start,
run, and grow their businesses more successfully. Information and advice
covering virtually every business and management task, including marketing,
sales, finding capital, managing people can be found at http://www.inc.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.
For further information:
For further information: Lois Paul & Partners Susan Lombardo,